These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 16821246

  • 1. Sequential and contingent prenatal screening for Down syndrome.
    Wald NJ, Rudnicka AR, Bestwick JP.
    Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
    [Abstract] [Full Text] [Related]

  • 2. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH, Caughey AB, Malone FD, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Emig D, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [Abstract] [Full Text] [Related]

  • 3. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
    Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K.
    Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
    [Abstract] [Full Text] [Related]

  • 4. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ, Bestwick JP, Morris JK.
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [Abstract] [Full Text] [Related]

  • 5. Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high-risk pregnant women.
    Guanciali-Franchi P, Iezzi I, Palka C, Matarrelli B, Morizio E, Calabrese G, Benn P.
    Prenat Diagn; 2011 Nov; 31(11):1077-81. PubMed ID: 21800336
    [Abstract] [Full Text] [Related]

  • 6. Combining first and second trimester markers for Down syndrome screening: think twice.
    Cocciolone R, Brameld K, O'Leary P, Haan E, Muller P, Shand K.
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
    [Abstract] [Full Text] [Related]

  • 7. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
    Palomaki GE, Steinort K, Knight GJ, Haddow JE.
    Obstet Gynecol; 2006 Feb; 107(2 Pt 1):367-75. PubMed ID: 16449126
    [Abstract] [Full Text] [Related]

  • 8. Three-stage contingent screening for Down syndrome.
    Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, Benn P.
    Prenat Diagn; 2006 Jun; 26(6):528-34. PubMed ID: 16634118
    [Abstract] [Full Text] [Related]

  • 9. Combined test + inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down syndrome.
    Ramos-Corpas DJ, Santiago JC.
    Prenat Diagn; 2008 Sep; 28(9):833-8. PubMed ID: 18661488
    [Abstract] [Full Text] [Related]

  • 10. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR, Morris TC, Owen J, Stringer JS.
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [Abstract] [Full Text] [Related]

  • 11. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P.
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract] [Full Text] [Related]

  • 12. Integrated serum screening for Down syndrome in primary obstetric practice.
    Knight GJ, Palomaki GE, Neveux LM, Smith DE, Kloza EM, Pulkkinen AJ, Williams J, Haddow JE.
    Prenat Diagn; 2005 Dec; 25(12):1162-7. PubMed ID: 16231402
    [Abstract] [Full Text] [Related]

  • 13. Advances in antenatal screening for Down syndrome.
    Wald NJ, Hackshaw AK.
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [Abstract] [Full Text] [Related]

  • 14. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.
    Odibo AO, Stamilio DM, Nelson DB, Sehdev HM, Macones GA.
    Obstet Gynecol; 2005 Sep; 106(3):562-8. PubMed ID: 16135588
    [Abstract] [Full Text] [Related]

  • 15. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA, Ying J, Beazoglou T, Egan JF.
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [Abstract] [Full Text] [Related]

  • 16. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P, Bussières L, Chevret S, Bernard JP, Malagrida L, Cuckle H, Chabry C, Durand-Zaleski I, Bidat L, Lacroix I, Moulis M, Roger M, Jacquemot MC, Bault JP, Boukobza P, Boccara P, Vialat F, Giudicelli Y, Ville Y.
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [Abstract] [Full Text] [Related]

  • 17. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD, Greene N, Johnson A, Zachary J, Thom E, Krantz D, Simpson JL, Silver RK, Snijders RJ, Goetzl L, Pergament E, Filkins K, Mahoney MJ, Hogge WA, Wilson RD, Mohide P, Hershey D, MacGregor S, Bahado-Singh R, Jackson LG, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group.
    Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
    [Abstract] [Full Text] [Related]

  • 18. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

  • 19. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [Abstract] [Full Text] [Related]

  • 20. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
    Wald NJ, Barnes IM, Birger R, Huttly W.
    Prenat Diagn; 2006 Jun; 26(6):539-44. PubMed ID: 16634123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.